These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8127215)

  • 1. Serum lactoferrin in lepromatous leprosy patients.
    Parkash OM; Girdhar BK; Sengupta U
    Lepr Rev; 1993 Dec; 64(4):295-301. PubMed ID: 8127215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leprosy patients with lepromatous disease recognize cross-reactive T cell epitopes in the Mycobacterium leprae 10-kD antigen.
    Hussain R; Dockrell HM; Shahid F; Zafar S; Chiang TJ
    Clin Exp Immunol; 1998 Nov; 114(2):204-9. PubMed ID: 9822277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium leprae infection and serum lactoferrin levels.
    Muruganand D; Daniel E; Ebenezer GJ; Rabboni SE; Segar P; Job CK
    Lepr Rev; 2004 Sep; 75(3):282-8. PubMed ID: 15508905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated free tear lactoferrin levels in leprosy are associated with Type 2 reactions.
    Daniel E; Duriasamy M; Ebenezer GJ; Shobhana ; Job CK
    Indian J Ophthalmol; 2004 Mar; 52(1):51-6. PubMed ID: 15132380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 beta production by monocytes from leprosy patients.
    Choi IH; Shin JS; Park SK; Cho SN; Kim JD; Kim SJ
    Yonsei Med J; 1990 Dec; 31(4):301-7. PubMed ID: 2077754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in lepromatous leprosy.
    Ochieng NA; Bwire MS; Orege PA; Nyawalo JO; K'Omollo JW
    Afr J Health Sci; 1994 May; 1(2):79-83. PubMed ID: 12153365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Levels of Migration Inhibitory Factor (MIF) and
    Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
    Front Immunol; 2018; 9():246. PubMed ID: 29487601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
    Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP.
    Hussain R; Lucas SB; Kifayet A; Jamil S; Raynes J; Uqaili Z; Dockrell HM; Chiang TJ; McAdam KP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):222-30. PubMed ID: 7602217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A; Hussain R
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
    Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
    Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum.
    Santos DO; Suffys PN; Bonifácio K; Marques MA; Sarno EN
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):199-203. PubMed ID: 8500267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chemiluminescence, procoagulant activity and antigen presentation by monocytes from lepromatous leprosy patients with or without reactional episodes.
    Santos DO; Suffys PN; Moreira AL; Bonifacio K; Salgado JL; Esquenazi D; Bertho AL; Sarno EN
    Lepr Rev; 1994 Jun; 65(2):88-99. PubMed ID: 7968194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.
    Dornelles LN; Pereira-Ferrari L; Messias-Reason I
    Clin Exp Immunol; 2006 Sep; 145(3):463-8. PubMed ID: 16907914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic phenomenon in leprosy.
    Jadhav VH; Jadhav MV; Sapatnekar SM; Joshi PB
    Indian J Lepr; 1990; 62(2):208-14. PubMed ID: 2212736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses.
    Hasan Z; Mahmood A; Zafar S; Khan AA; Hussain R
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):35-44. PubMed ID: 15217317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.